Cancer
The neoadjuvant chemoimmunotherapy pathway has become the standard of care for patients with resectable, locally advanced non-small cell lung cancer without actionable mutations. Its increasing use has introduced novel technical challenges, as fibrotic changes, inflammatory...
…This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with David Waller, Chair of the EACTS Emphysema Taskforce and Director of the EACTS Fundamentals Course in Thoracic Surgery, about...
Mediastinal and intrathoracic germ cell tumors are rare in the pediatric population, and extragonadal yolk sac tumors presenting as giant thoracic masses are rarer still. These tumors pose a dual...
In this episode of The Atrium, host Alice Copperwheat speaks with Jessica Donington, Professor of Surgery and Chief of the Section of Thoracic Surgery at the University of Chicago, Illinois,...
The role of surgery in locally advanced non-small cell lung cancer (NSCLC) is continuously evolving with the introduction of effective neoadjuvant systemic treatments. Beyond tumor reduction, treatment response may influence...
